Feasibility of high-resolution quantitative perfusion analysis in patients with heart failure

Journal of Cardiovascular Magnetic Resonance

Volumn 17, Issue 1, 2015, Pages

  Sammut, Eva ^a   Zarinabad, Niloufar ^a   Wesolowski, Roman ^a   Morton, Geraint ^a   Chen, Zhong ^a   Sohal, Manav ^a   Carr White, Gerry ^b   Razavi, Reza ^a   Chiribiri, Amedeo ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Cardiovascular magnetic resonance; Gadolinium; Heart failure; Quantitative perfusion

Indexed keywords

GADOBUTROL; GADOLINIUM;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CONTROLLED STUDY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE PERFUSION; HUMAN; IMAGE ENHANCEMENT; IMAGE QUALITY; ISCHEMIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; NONISCHEMIC CARDIOMYOPATHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; AGED; COMPUTER ASSISTED DIAGNOSIS; CORONARY ARTERY BLOOD FLOW; CORONARY BLOOD VESSEL; EVALUATION STUDY; FEASIBILITY STUDY; HEART STROKE VOLUME; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; RETROSPECTIVE STUDY;

ADULT; AGED; CORONARY CIRCULATION; CORONARY VESSELS; FEASIBILITY STUDIES; FEMALE; HEART FAILURE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 84924267603     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/s12968-015-0124-2     Document Type: Article

References (43)

1. Shaw LJ, Berman DS, Maron DJ, Mancini GBJ, Hayes SW, Hartigan PM, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial nuclear sub study. Circulation. 2008;117:1283-91.
2. Cowie MR, Wood DA, Coats AJ, Thompson SG, Suresh V, Poole-Wilson PA, et al. Survival of patients with a new diagnosis of heart failure: a population based study. Heart. 2000;83(5):505-10.
3. Hobbs FDR, Roalfe AK, Davis RC, Davies MK, Hare R, and the Midlands Research Practices Consortium (MidReC). Prognosis of all-cause heart failure and borderline left ventricular systolic dysfunction: 5 year mortality follow up of the Echocardiographic Heart of England Screening Study (ECHOES). Eur Heart J. 2007;28:1128-34.
4. Neglia D, Michalassi C, Trivieri MG, Sambuceti G, Giorgetti A, Pratali L et al. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation. 2002;105(2):186-93.
5. Fang W, Zhang J, He Z-X. Myocardial ischemia in patients with dilated cardiomyopathy. Nucl Med Commun. 2010;31:981-4.
6. Sobajima M, Nozawa T, Suzuki T, Ohori T, Shida T, Matsuki A, et al. Impact of myocardial perfusion abnormality on prognosis in patients with non-ischemic dilated cardiomyopathy. J Cardiol. 2010;56:280-6.
7. Abbasi SA, Ertel A, Shah RV, Dandekar V, Chung J, Bhat G, et al. Impact of cardiovascular magnetic resonance on management and clinical decision-making in heart failure patients. J Cardiovasc Magn Reson. 2013;15:1.
8. Karamitsos TD, Francis JM, Myerson S, Selvanayagam JB, Neubauer S. The role of cardiovascular magnetic resonance imaging in heart failure. J Am Coll Cardiol. 2009;54:1407-24.
9. Myerson SG, Bellenger NG, Pennell DJ. Assessment of left ventricular mass by cardiovascular magnetic resonance. Hypertension. 2002;39:750-5.
10. Klein C. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation. 2002;105:162-7.
11. Schwitter J, Nanz D, Kneifel S, Bertschinger K, Buchi M, Knusel PR, et al. Assessment of myocardial perfusion in coronary artery disease by magnetic resonance : a comparison with positron emission tomography and coronary angiography. Circulation. 2001;103:2230-5.
12. Schwitter J, Wacker CM, van Rossum AC, Lombardi M, Al-Saadi N, Ahlstrom H, et al. MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J. 2008;29:480-9.
13. McCrohon JA. Differentiation of heart failure related to dilated cardio myopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation. 2003;108:54-9.
14. Morton G, Ishida M, Schuster A, Hussain S, Schaeffter T, Chiribiri A, et al. Perfusion cardiovascular magnetic resonance: comparison of an advanced, high-resolution and a standard sequence. J Cardiovasc Magn Reson. 2012;14:1.
15. Plein S, Ryf S, Schwitter J, Radjenovic A, Boesiger P, Kozerke S. Dynamic contrast-enhanced myocardial perfusion MRI accelerated with k-t sense. Magn Reson Med. 2007;58:777-85.
16. Hussain ST, Paul M, Plein S, McCann GP, Shah AM, Marber MS, et al. Design and rationale of the MR-INFORM study: stress perfusion cardiovascular magnetic resonance imaging to guide the management of patients with stable coronary artery disease. J Cardiovasc Magn Reson. 2012;14:1.
17. Ishida M, Schuster A, Morton G, Chiribiri A, Hussain S, Paul M, et al. Development of a universal dual-bolus injection scheme for the quantitative assessment of myocardial perfusion cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2011;13:28.
18. Kremers FPPJ, Hofman MBM, Groothuis JGJ, Jerosch-Herold M, Beek AM, Zuehlsdorff S, et al. Improved correction of spatial inhomogeneities of surface coils in quantitative analysis of first-pass myocardial perfusion imaging. J Magn Reson Imaging. 2009;31:227-33.
19. Zarinabad N, Chiribiri A, Hautvast GLTF, Ishida M, Schuster A, Cvetkovic Z, et al. Voxel-wise quantification of myocardial perfusion by cardiac magnetic resonance. Feasibility and methods comparison. Magn Reson Med. 2012;68:1994-2004.
20. Morton G, Chiribiri A, Ishida M, Hussain ST, Schuster A, Indermuehle A, et al. Quantification of absolute myocardial perfusion in patients with coronary artery disease. J Am Coll Cardiol. 2012;60:1546-55.
21. Hautvast G, Chiribiri A, Zarinabad N, Schuster A, Breeuwer M, Nagel E. Myocardial blood flow quantification from MRI by deconvolution using an exponential approximation basis. IEEE Trans Biomed Eng. 2012;59(7):2060-7.
22. Wilke N, Jerosch-Herold M, Wang Y, Huang Y, Christensen BV, Stillman AE et al. Myocardial perfusion reserve: assessment with multi section, quantitative, first-pass MR imaging. Radiology. 1997;204(2):373-84.
23. Jerosch-Herold M, Wilke N, Stillman AE, Wilson RF. Magnetic resonance quantification of the myocardial perfusion reserve with a Fermi function model for constrained deconvolution. Med Phys. 1998;25:73.
24. Zarinabad N, Hautvast GL, Sammut E, Arujuna A, Breeuwer M, Nagel E, et al. Effects of tracer arrival time on the accuracy of high-resolution (voxel-wise) myocardial perfusion maps from contrast-enhanced first-pass perfusion magnetic resonance. IEEE Trans Biomed Eng. 2014;61(9):2499-506.
25. Jerosch-Herold MM, Wilke NN, Stillman AEA. Magnetic resonance quantification of the myocardial perfusion reserve with a Fermi function model for constrained deconvolution. Med Phys. 1998;25:73-84.
26. Gerber BL. Quantification of myocardial perfusion and myocardial perfusion reserve by positron emission tomography and cardiovascular magnetic resonance imaging. J Am Coll Cardiol. 2012;60:1556-7.
27. Bruder O, Schneider S, Nothnagel D, Dill T, Hombach V, Schulz-Menger J, et al. Euro CMR (European Cardiovascular Magnetic Resonance) Registry. J Am Chem Soc. 2009;54:1457-66.
28. Neglia D. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation. 2002;105:186-93.
29. Greenwood JP, Maredia N, Radjenovic A, Brown JM, Nixon J, Farrin AJ, et al. Clinical evaluation of magnetic resonance imaging in coronary heart disease: the CE-MARC study. Trials. 2009;10:62.
30. Schwitter J, Arai AE. Assessment of cardiac ischaemia and viability: role of cardiovascular magnetic resonance. Eur Heart J. 2011;32:799-809.
31. Lockie T, Ishida M, Perera D, Chiribiri A, De Silva K, Kozerke S, et al. High-resolution magnetic resonance myocardial perfusion imaging at 3.0-tesla to detect hemodynamically significant coronary stenoses as determined by fractional flow reserve. J Am Coll Cardiol. 2011;57:70-5.
32. Costa MA, Shoemaker S, Futamatsu H, Klassen C, Angiolillo DJ, Nguyen M, et al. Quantitative magnetic resonance perfusion imaging detects anatomic and physiologic coronary artery disease as measured by coronary angiography and fractional flow reserve. J Am Coll Cardiol. 2007;50:514-22.
33. Christian TF, Aletras AH, Arai AE. Estimation of absolute myocardial blood flow during first-pass MR perfusion imaging using a dual-bolus injection technique: comparison to single-bolus injection method. J Magn Reson Imaging. 2008;27:1271-7.
34. Lee DC. Magnetic resonance versus radionuclide pharmacological stress perfusion imaging for flow-limiting stenoses of varying severity. Circulation. 2004;110:58-65.
35. Motwani M, Maredia N, Fairbairn TA, Kozerke S, Radjenovic A, Greenwood JP, et al. High-resolution versus standard-resolution cardiovascular MR myocardial perfusion imaging for the detection of coronary artery disease. Circ Cardiovasc Imaging. 2012;5:306-13.
36. van den Heuvel AFM, van Veldhuisen DJ, van der Wall EE, Blanksma PK, Siebelink H-MJ, Vaalburg WM, et al. Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 2000;35:19-28.
37. Masci PG, Marinelli M, Piacenti M, Lorenzoni V, Positano V, Lombardi M, et al. Myocardial structural, perfusion, and metabolic correlates of left bundle branch block mechanical derangement in patients with dilated cardiomyopathy: a tagged cardiac magnetic resonance and positron emission tomography study. Circ Cardiovasc Imaging. 2010;3:482-90.
38. Neglia D, Parodi O, Gallopin M, Sambuceti G, Giorgetti A, Pratali L, et al. Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure: a quantitative assessment by positron emission tomography. Circulation. 1995;92:796-804.
39. Tio RA, Slart RHJA, de Boer RA, van der Vleuten PA, de Jong RM, van Wijk LM, et al. Reduced regional myocardial perfusion reserve is associated with impaired contractile performance in idiopathic dilated cardio myopathy. Neth Heart J. 2009;17:470-4.
40. Parodi O, De Maria R, Oltrona L, Testa R, Sambuceti G, Roghi A, et al. Myocardial blood flow distribution in patients with ischemic heart disease or dilated cardio myopathy undergoing heart transplantation. Circulation. 1993;88:509-22.
41. Kremser CB, O'Toole MF, Leff AR. Oscillatory hyperventilation in severe congestive heart failure secondary to idiopathic dilated cardio myopathy or to ischemic cardio myopathy. Am J Cardiol. 1987;59:900-5.
42. Feld H, Priest S. A cyclic breathing pattern in patients with poor left ventricular function and compensated heart failure: A mild form of cheyne-stokes respiration. JACC. 1993;21(4):971-974.
43. Yahima T, Koike A, Sugimoto K, Miyahara Y, Marumo F, Hiroe M. Mechanism of periodic breathing in patients with cardiovascular disease. Chest. 1994;106:142-146.